Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20253253 | 0.95 | ALDH1A1 (0.40) | ALDH1A1CYP3A4CA2TSHRLMNA | |
| SCHEMBL17133195 | 0.85 | ALDH1A1 (0.31) | ALDH1A1CYP3A4CA2TSHRLMNA | |
| SCHEMBL15713211 | 0.82 | — | — | |
| SCHEMBL16884884 | 0.79 | ALDH1A1 (0.39) | ALDH1A1CYP3A4CA2TSHRLMNA | |
| SCHEMBL20253254 | 0.79 | ALDH1A1 (0.40) | ALDH1A1CYP3A4CA2TSHRLMNA | |
| SCHEMBL20253227 | 0.77 | ALDH1A1 (0.37) | ALDH1A1CYP3A4CA2TSHRLMNA | |
| SCHEMBL17112416 | 0.76 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CA2TSHRLMNA | |
| SCHEMBL18434805 | 0.75 | — | — | |
| SCHEMBL18461728 | 0.75 | ALDH1A1 (0.37) | ALDH1A1CYP3A4CA2TSHRLMNA | |
| SCHEMBL20253256 | 0.74 | ALDH1A1 (0.43) | ALDH1A1CYP3A4CA2TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10355214-B2 | Copolymer and organic solar cell comprising same | LG CHEM, LTD. (KR) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10355214-B2 | Copolymer and organic solar cell comprising same | OR10J3, CRY1, STOM | ALDH1A1 3326/4885CYP3A4 3385/4885CA2 387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.